Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

His team harnesses advanced computational technologies, including AI, with the aim of enhancing the discovery, design, optimization and synthesis of small molecules to be developed into innovative ...

The new software ... modelling, AI, and cloud computing towards improving existing computational methods while exploring new algorithms to address a wide range of drug design challenges.

His research explores the rise of generative AI and accelerated use of AI more broadly to advance drug and scientific discovery. Reuben leads Gartner's coverage of genomics, multiomics, cell and gene ...

Developed by SECQAI, the QLLM enhances traditional AI models with quantum computing for improved efficiency and ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors, and the general public. Researchers have ...

For more information, or to register for this event, visit A Rare Look into New Guidances: The Future State of Orphan Drug Development.

researchers can digitize biological inner workings to better identify drug targets, predict their efficacy and potential toxicity, optimize design, and model the interactions between drugs and ...